IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal


PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In October 2023, Northern TK Venture (NTK), a subsidiary of IHH Healthcare, had filed a claim against the Japanese pharmaceuticals manufacturer saying it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Moody’s: South, Southeast Asia credit outlook stable despite US dollar strength
South Korea's KOSPI craters over 8% as Fed fears spark tech rout
Gold extends losses on US interest rate-hike fears
OCBC to offer physical gold trading, storage in Singapore
Indonesia's FX reserves slide to two-year low, sparking concern�
US allegations of forced labor refuted
Chipmakers drag South Korea, Taiwan stocks lower as investors unwind AI bets
Liftech to raise RM23mil from ACE Market IPO
Yuan brushes off dollar strength, trade data eyed
Supply crisis to push costs beyond oil prices, whole-of-nation response needed

Others Also Read